Elevance Health ELV Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $200.42B+0.6% | $199.13B+2.2% | $194.82B+3.0% | $189.22B+3.2% | $183.33B+3.6% | ||
| $21.66B+2.3% | $21.18B-2.3% | $21.67B+1.3% | $21.38B+2.3% | $20.91B+5.9% | ||
| $178.76B+0.5% | $177.95B+2.8% | $173.15B+3.2% | $167.83B+3.3% | $162.42B+3.3% | ||
| 89.2%-0.2pp | 89.4%+0.5pp | 88.9%+0.2pp | 88.7%+0.1pp | 88.6%-0.2pp | ||
| $22.01B+4.9% | $20.98B+3.0% | $20.37B0.0% | $20.37B-0.3% | $20.44B+2.1% | ||
| $1.42B+0.9% | $1.4B+1.9% | $1.38B+3.8% | $1.33B+4.8% | $1.26B+6.7% | ||
| $6.22B-7.3% | $6.71B-5.5% | $7.1B+0.5% | $7.07B-8.9% | $7.76B-1.8% | ||
| —— | —— | $1.57B-8.5% | $1.72B-7.4% | $1.86B-4.0% | ||
| $5.24B-7.4% | $5.66B+2.3% | $5.53B+3.2% | $5.36B-9.4% | $5.92B-1.1% | ||
| 2.6%-0.2pp | 2.8%0.0pp | 2.8%0.0pp | 2.8%-0.4pp | 3.2%-0.2pp | ||
| $23.58-6.4% | $25.19+2.7% | $24.52+4.1% | $23.56-8.3% | $25.69+0.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Elevance Health's revenue?
- Elevance Health (ELV) generated $200.42B in revenue over the trailing twelve months, up 9.3% year over year.
- Is Elevance Health profitable?
- Elevance Health reported $5.2B in net income over the trailing twelve months, a 2.6% net margin.
- What is Elevance Health's earnings per share?
- Elevance Health's diluted EPS over the trailing twelve months is $23.58.
- Where does Elevance Health's income statement data come from?
- Every line is extracted from Elevance Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
